Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sprout Health vs Breeze Meds

Two GLP-1 desks, one scoreboard. We put Sprout Health and Breeze Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 6 · Grade B

Sprout Health

Visit Sprout Health Full brief →
vs
No. 37 · Grade C

Breeze Meds

Visit Breeze Meds Full brief →

The verdict

Sprout Health takes this head-to-head.

Sprout Health scores 86 to 76 on our six-factor Brief Score — A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

That doesn't make Breeze Meds a bad call — it's best for readers starting at a low dose who want nothing charged until a provider has approved them. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
70
Supply Reliability
82
82
Transparency
88
60
Access Breadth
92
88
Clinical Oversight
78
78
Track Record
84
76
Sprout HealthBrief Score 86 · 76Breeze Meds

Price, coverage & the tracker

Sprout HealthBreeze Meds
Brief Score86/100 (B)76/100 (C)
Semaglutide$149/moFrom $199/mo injectable · $299/mo oral (lowest dose)
Tirzepatide$199/moFrom $399/mo injectable · $399/mo oral (lowest dose)
CoverageNot disclosedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

Sprout Health: Compounded $149 semaglutide / $199 tirzepatide held flat this cycle, with a brand-name Wegovy/Zepbound path available on the same account.

Breeze Meds: ⚠ Every published figure is quoted at the LOWEST dose — the funnel says higher doses may cost more, so these are floors.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.